Multinational pharmaceutical and biotech company Pfizer and AI-powered data company Tempus announced a multiyear strategic alliance to utilize AI and machine learning to inform drug discovery and development in oncology.
Pfizer will leverage Tempus' library of de-identified data to accelerate therapeutic development in oncology. It will also use Tempus' AI-driven companion diagnostic offerings...
British multinational pharmaceutical and biotech company GSK announced a three-year agreement with a $70 million initial payment to expand its access to Tempus' AI-powered data library, including its de-identified patient data.
GSK says the collaboration will allow it to leverage the U.S.-based company's library to accelerate drug discovery in oncology, improve its clinical trial design,...
Dentist gone digital. On Friday CareStack, a cloud-based technology company that caters to the dental industry, announced that it scored $16 million in funding. The round was led by Accel, F-Prime Capital Partners, and Eight Roads Ventures.
“CareStack is helping dental practices across the country gain better control of their operations, which is leading to better patient care. We are excited to...
Beginning this fall, Aetna will combine Apple’s consumer tech offerings with its analytics-based wellness and care management programs by integrating several iOS-exclusive health initiatives. First off, the company will make the Apple Watch available to some of its large employers and individual members during open enrollment season, and will be subsidizing part of the cost. Aetna will also be...
